References
- BergEBPicardRJIn vitro delivery of budesonide from 30 jet nebulizer/compressor combinations using infant and child breathing patternsRespir Care200954121671167819961633
- SmaldoneGCCruz-RiveraMNikanderKIn vitro determination of inhaled mass and particle distribution for budesonide nebulizing suspensionJ Aerosol Med1998112113125
- HessDRNebulizers: principles and performanceRespir Care200045660962210894454
- European Committee for StandardizationCEN: EN 13544-1: 2007+A1:2009: Respiratory Therapy Equipment: Nebulizing Systems and Their ComponentsLondonBritish Standards Institute2010
- US PharmacopoeiaChapter 1601: Products for nebulization – characterization testsUnited States Pharmacopeia (USP) 35Rockville (MD)USP2012
- European PharmacopoeiaChapter 2.9.44: Preparations for nebulisation – characterisationEuropean Pharmacopeia (EP) 7.3StrasbourgEuropean Directorate for the Quality of Medicines and Healthcare2010
- International Organization for StandardizationISO 27427:2013(E): Anaesthetic and Respiratory Equipment: Nebulizing Systems and ComponentsGenevaISO2013
- US PharmacopoeiaChapter 1601: Products for nebulization – characterization testsUnited States Pharmacopoeia (USP) 37Rockville (MD)USP2014
- US Pharmacopoeia (USP)Chapter 1601: Products for nebulization – characterization testsUnited States Pharmacopeia (USP) 40Rockville (MD)USP2017
- HeyderJGebhartJRudolfGSchillerCFStahlhofenWDeposition of particles in the human respiratory tract in the size range of 0.005–15 µmJ Aerosol Sci1986175811825
- BauerAMcGlynnPBovetLLMimsPLCurryLAHanrahanJPThe influence of breathing pattern during nebulization on the delivery of arformoterol using a breath simulatorRespir Care200954111488149219863833
- GatnashAAChandlerSTConnollyCKA new method for measuring aerosol nebulizer output using radioactive tracersEur Respir J19981224674719727803
- SmaldoneGCSangwanSShahAFacemask design, facial deposition, and delivered dose of nebulized aerosolsJ Aerosol Med200720Suppl 1S66S7717411408
- SchüeppKGJauernigJJanssensHMIn vitro determination of the optimal particle size for nebulized aerosol delivery to infantsJ Aerosol Med200518222523515966777
- NikanderKDenyerJEverardMSmaldoneGCValidation of a new breathing simulator generating and measuring inhaled aerosol with adult breathing patternsJ Aerosol Med200013213914611010594
- SkariaSSmaldoneGCOmron NE U22: comparison between vibrating mesh and jet nebulizerJ Aerosol Med Pulm Drug Deliv201023317318020500093
- AriAde AndradeADFinkJBPerformance comparisons of jet and mesh nebulizers with mouthpiece, aerosol mask, and valved mask in simulated spontaneously breathing adultsChest2014145Suppl 3548A
- TobinMJChadhaTSJenouriGBirchSJGazerogluHBSacknerMABreathing patterns – 1: normal subjectsChest19838422022056872603
- CarterRTashkinDDjahedBHathawayENicotraMBTiepBLDemand oxygen delivery for patients with restrictive lung diseaseChest1989966130713112582836
- TobinMJChadhaTSJenouriGBirchSJGazerogluHBSacknerMABreathing patterns – 2: diseased subjectsChest19838432862946884104
- LoringSHGarcia-JacquesMMalhotraAPulmonary characteristics in COPD and mechanisms of increased work of breathingJ Appl Physiol2009107130931419359620
- DíazOVillafrancaCGhezzoHBreathing pattern and gas exchange at peak exercise in COPD patients with and without tidal flow limitation at restEur Respir J20011761120112711491153
- DenyerJDycheTThe adaptive aerosol delivery (AAD) technology: past, present, and futureJ Aerosol Med Pulm Drug Deliv201023Suppl 1S1S10
- NikanderKDenyerJBreathing patternsEur Respir Rev20001076576579
- VitaccaMCliniEPortaRFoglioKAmbrosinoNAcute exacerbations in patients with COPD: predictors of need for mechanical ventilationEur Respir J199697148714938836664
- BauerleOChruschCAYounesMMechanisms by which COPD affects exercise toleranceAm J Respir Crit Care Med1998157157689445279
- VogiatzisIStratakosGAthanasopoulosDChest wall volume regulation during exercise in COPD patients with GOLD stages II to IVEur Respir J2008321425218321930
- MitchellJPWhy clinically appropriate in vitro inhaler testing? Introducing the patient experience into the picture Available from: http://www.fda.gov/downloads/forindustry/userfees/genericdruguserfees/UCM398876.pdfAccessed December 3, 2015